Back

FYCO1 ameliorates adverse cardiac remodeling in response to myocardial ischemia by enhancing autophagic flux

29 August 2022 (16:55 - 17:05)
Organised by:
Congress Presentation Part of: Myocardial ischaemia and protective mechanisms Ischaemia, Infarction, Cardioprotection ESC Professional Premium Access ESC Congress 2022

About the speaker

Photo
Miss Frauke Senger

University Hospital Heidelberg, Heidelberg (Germany)

4 More presentations in this session

Presentation thumbnail
Impaired Cardioprotection by HDL in CAD and Diabetes in Ischemia/Reperfusion Injury: role of S1P and SR-BI
Doctor A. Polzin (Duesseldorf, DE)
Abstract Slides Video
Presentation thumbnail
Systemic GDF11 replenishment ignites myocardial injury through diminishing anti-apoptotic activity of cardiac progenitor cells
Doctor S. Kraler (Bern, CH)
Abstract Slides Video
Presentation thumbnail
Cardioprotection by selective SGLT2 inhibitors in a non-diabetic mouse model of myocardial ischemia/reperfusion injury: a class or a drug effect?
Doctor P. Nikolaou (Athens, GR)
Abstract Slides Video
Presentation thumbnail
Erythrocytes from patients with ST-elevation myocardial infarction induce cardioprotection via the purinergic P2Y13 receptor and nitric oxide signalling
Doctor T. JIAO (Stockholm, SE)
Abstract Slides Video

Access the full session

Session thumbnail
Myocardial ischaemia and protective mechanisms

The Event

Event poster

ESC Congress 2022

29 August 2022 16:55 CET
You may be interested in
thumbnail
Congress Presentation
EVs derived from physiologically loaded myocardial slices affect remodelling of overloaded myocardial slices
thumbnail
Congress Session
Organelle stress in cardiovascular disease
thumbnail
Congress Presentation
Dysbiotic microbiome induce cardiac impairment by attenuating brain-derived neurotrophic factor in inflammatory bowel diseases

ESC 365 is supported by

novartis Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources